首页> 外文OA文献 >Performance of new gellan gum hydrogels combined with human articular chondrocytes for cartilage regeneration when subcutaneously implanted in nude mice
【2h】

Performance of new gellan gum hydrogels combined with human articular chondrocytes for cartilage regeneration when subcutaneously implanted in nude mice

机译:新型结冷胶水凝胶与人关节软骨细胞联合皮下植入裸鼠的软骨再生性能

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Gellan gum is a polysaccharide that has been recently proposed by our group for cartilage tissueengineeringapplications. It is commonly used in the food and pharmaceutical industry and hasthe ability to form stable gels without the use of harsh reagents. Gellan gum can function as aminimally invasive injectable system, gelling inside the body in situ under physiological conditionsand efficiently adapting to the defect site. In this work, gellan gum hydrogels were combined withhuman articular chondrocytes (hACs) and were subcutaneously implanted in nude mice for 4 weeks.The implants were collected for histological (haematoxylin and eosin and Alcian blue staining),biochemical [dimethylmethylene blue (GAG) assay], molecular (real-time PCR analyses for collagentypes I, II and X, aggrecan) and immunological analyses (immunolocalization of collagen types I andII). The results showed a homogeneous cell distribution and the typical round-shaped morphologyof the chondrocytes within the matrix upon implantation. Proteoglycans synthesis was detected byAlcian blue staining and a statistically significant increase of proteoglycans content was measuredwith the GAG assay quantified from 1 to 4 weeks of implantation. Real-time PCR analyses showed astatistically significant upregulation of collagen type II and aggrecan levels in the same periods. Theimmunological assays suggest deposition of collagen type II along with some collagen type I. Theoverall data shows that gellan gum hydrogels adequately support the growth and ECM depositionof human articular chondrocytes when implanted subcutaneously in nude mice.
机译:结冷胶是我们小组最近在软骨组织工程应用中提出的一种多糖。它通常用于食品和制药行业,并且能够在不使用刺激性试剂的情况下形成稳定的凝胶。结冷胶可作为一种微创注射系统,在生理条件下在体内原位凝胶化,并有效适应缺损部位。在这项工作中,结冷胶水凝胶与人类关节软骨细胞(hACs)结合,皮下植入裸鼠中4周。收集植入物用于组织学检查(苏木精和曙红和Alcian蓝染色),生化[二甲基亚甲基蓝(GAG)分析],分子(I型,II型和X型胶原蛋白的实时PCR分析,聚集蛋白聚糖)和免疫学分析(I型和II型胶原蛋白的免疫定位)。结果显示,植入后基质中的软骨细胞具有均匀的细胞分布和典型的圆形形态。蛋白聚糖的合成通过阿尔辛蓝染色进行检测,并通过植入1至4周后进行定量的GAG分析检测到蛋白聚糖含量具有统计学意义的增加。实时PCR分析显示,同一时期II型胶原蛋白和聚集蛋白聚糖水平明显升高。免疫学分析表明,II型胶原蛋白与一些I型胶原蛋白一起沉积。总体数据显示,结冷胶水凝胶在裸鼠皮下植入时能充分支持人关节软骨细胞的生长和ECM沉积。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号